Seminars in Hematology
Volume 43, Supplement 4 , Pages S18-S21, April 2006

Surgery in Patients With Hemophilia and Inhibitors: A Review of the Norwegian Experience With FEIBA

  • Geir E. Tjønnfjord

      Affiliations

    • Corresponding Author InformationAddress correspondence to Geir E. Tjønnfjord, MD, PhD, Medical Department, Division of Hematology, Rikshospitalet–Radiumhospitalet University Hospital, N-0027 Oslo, Norway.

Medical Department, Division of Hematology, Rikshospitalet–Radiumhospitalet University Hospital, University of Oslo, Oslo, Norway.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This manuscript is based in part on the proceedings from an educational symposium held at the World Federation of Hemophilia World Congress 2004 in Bangkok, Thailand. Both the symposium and this manuscript were supported by Baxter Healthcare Corporation.

PII: S0037-1963(06)00049-7

doi:10.1053/j.seminhematol.2006.03.003

Seminars in Hematology
Volume 43, Supplement 4 , Pages S18-S21, April 2006

Article Tools